Drug: zyrtec Quarter: 2016Q3
Total Drug/Injury Combinations: 456 Number of Pages: 23
DRUGNAME | PT | EventCount | |
---|---|---|---|
ZYRTEC | Non-small cell lung cancer stage IV | 3 | view events |
ZYRTEC | Paraesthesia | 3 | view events |
ZYRTEC | Physical product label issue | 3 | view events |
ZYRTEC | Post-traumatic stress disorder | 3 | view events |
ZYRTEC | Rheumatoid arthritis | 3 | view events |
ZYRTEC | Skin haemorrhage | 3 | view events |
ZYRTEC | Throat irritation | 3 | view events |
ZYRTEC | Tinnitus | 3 | view events |
ZYRTEC 10MG IR TABLET | Drug effect decreased | 3 | view events |
ZYRTEC 10MG IR TABLET | Drug ineffective for unapproved indication | 3 | view events |
ZYRTEC ALLERGY | Drug ineffective for unapproved indication | 3 | view events |
ZYRTEC ALLERGY | Incorrect dose administered | 3 | view events |
ZYRTEC-D | Drug ineffective for unapproved indication | 3 | view events |
ZYRTEC | Abnormal behaviour | 2 | view events |
ZYRTEC | Accidental exposure to product packaging | 2 | view events |
ZYRTEC | Acne | 2 | view events |
ZYRTEC | Adverse event | 2 | view events |
ZYRTEC | Adverse reaction | 2 | view events |
ZYRTEC | Anaplastic lymphoma kinase gene mutation | 2 | view events |
ZYRTEC | Aphasia | 2 | view events |
Total Drug/Injury Combinations: 456 Number of Pages: 23
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)